I have said this before, I cannot believe that although GILD is giving such discounts that they are not being paid on the front end - If I came to you and said that I would discount your entire patient base 44% though for this to happen we need upfront payment for the first 80%,
Take a look at Credit Suisse history of opinions of GILD
These guys are like weathermen sticking their heads outside a window - This analyst should pay to work there rather than the other way around
I understand that the discounting of essential drugs is normal in the industry though can't this be offset some by the drug manufacturer requesting that that a certain percentage of Rx to be filled be paid lump sum in advance ? I am not by far a genius but the seems practical to me.
Harvoni / Solvadi cure Hep C as I understand it though will it prevent Hep C ?
My reasoning is that Hep C will continue to flourish and that yes, the patient pool will diminish but there will be a long term requirement for this drug.
Amazing thing to me is that the market is punishing GILD for finding a cure.
Company has 100 M shares outstanding, Institutions bought long ago and are still seeing profits though right now they are driving the price down to buy more on the cheap - Blackstone buying 5+ % of the company is the tip off - company being set up for a sale. I will be in at 11, company may go for 1, 3 to 1.4 B - maybe a 20% gain -
Blackstone does not get things wrong, Blacksotone loves the bleeding of this company - makes it much easier for them to recommend to shareholders that this company should sell out and that they will handle the transaction. The weak get eaten
Edgar filing indicates that Blackstone has a 5+ % ownership stake in ACHN ( Filed 1/29?2015 ) - I am taking a very close look into this company now, I think 11.00 or lower would be a good entry - though I don't think it will be bought out until Q3 - Yes, it fell in sympathy with GILD but the smart money right now is buying companies in this space that are profitable after Tuesdays fall.
You don't get it - If GILD priced their Hep C drugs at half of what they did the Express Scripts folks would still be #$%$, a huge number of their clients are afflicted and they would have done anything that they could to get the price lower .
Just like your auto insurance carrier - all insurance companies bottom line are derived from who the screw over - the Rx supplier or the insured, they don't care.
Big time head fake - would really be shocked if it opened tomorrow down the 4.8% it is now. In fact I would not be surprised that the close tomorrow is higher than todays
Analysts freaked about the low guidance though they guided at most 4% lower than estimates - note that I am certain that GILD factored in any discounts in their guidance -
Of course it is proprietary - Insurance companies need to markup the cost to make money
MMs are doing a great job of shaking out the skittish retail investors. Will close at the pre market high at minimum
How can you tell that insiders are selling in real time, YOU CAN'T
Hey, I personally have access to 100% of those afflicted with Hep C - just contact me.
ABBV CEO is so full of #$%^
ABBV CEO is spinning his statements, in that by saying they have "access" to these patients via their Express Scripts deal but doesn't mention that many insurers that have Express Scripts contracted have made direct deals with GILD. These are misleading statements and that if I were a law firm would see an opportunity to work on ABBV shareholders behalf. If I were a ABBV shareholder, I would be selling my position immediately.
And one wonders why you can't trust big business - this CEO should be fired immediately and shame on the analysts for not putting him on the spot after making such statements